HIV Drug Settlement Reached to Resolve Class Action Over Truvada, Stribild, Other Antiretrovirals
Bristol-Myers Squibb has agreed to pay $10 million to resolve its part in the class action lawsuit over HIV drugs with allegedly inflated prices.
January 03, 2022 By: Irvin Jackson
Bristol-Myers Squibb has agreed to pay $10 million to resolve its part in the class action lawsuit over HIV drugs with allegedly inflated prices.
A federal judge has rejected plaintiffs' request to reopen the discovery and deposition process in BioZorb lawsuits following last October's global recall of the tissue markers.
Plaintiffs and defendants involved in hair relaxer lawsuits have told a federal judge they are close to selecting a mediator or special master to oversee potential settlement talks.
Plaintiffs involved in Suboxone dental lawsuits indicate the bellwether selection process may be delayed due to the defendants' approach to the discovery process, which they say will cause significant delays in the litigation.
"*" indicates required fields